Impact of changing oxygenation policies on retinopathy of prematurity in a neonatal unit in Argentina

Br J Ophthalmol. 2012 Dec;96(12):1456-61. doi: 10.1136/bjophthalmol-2011-301394. Epub 2012 Oct 4.

Abstract

Aims: To assess the impact of different oxygenation policies on the rate and severity of retinopathy of prematurity (ROP).

Methods: Between January 2003 and December 2006, infants of 1500 g birthweight (BW) or less and/or 32 weeks gestational age (GA) or less, and larger, more mature infants with risk factors for ROP were examined through three different time periods: period 1: high target oxygen saturation levels (88-96%) and treatment at threshold ROP; period 2: low target oxygen saturation levels (83-93%) and treatment at threshold ROP; period 3: low target oxygen saturation and treatment at type 1 ROP.

Results: Type 1 ROP was detected more frequently in babies of 32 weeks GA or less (50/365, 13.7%) than in more mature babies (15/1167, 1.3%; p<0.001). The rate of type 1 ROP in period 1 was 6.9%; period 2, 3.6% and period 3, 1.8%. Rates of stage 3 ROP declined over time in both BW/GA groups (from 9.0% to 4.1% to 2.0%) as did rates of plus disease (from 7.5% to 3.6% to 1.8%). Mean BW and GA declined from period 1 to period 3, and death rates remained unchanged. 74.4% of babies received all the examinations required; 48.1% of treatments were undertaken after discharge from the neonatal unit.

Conclusions: Lower target oxygen saturation was associated with a lower rate of severe ROP without increasing mortality, and changed the characteristics of affected babies. Screening criteria need to remain wide enough to identify all babies at risk of ROP needing treatment.

Publication types

  • Comparative Study

MeSH terms

  • Argentina / epidemiology
  • Follow-Up Studies
  • Gestational Age
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Infant, Very Low Birth Weight
  • Intensive Care Units, Neonatal*
  • Oxygen Consumption / physiology*
  • Oxygen Inhalation Therapy / standards*
  • Practice Guidelines as Topic*
  • Retinopathy of Prematurity / metabolism
  • Retinopathy of Prematurity / mortality
  • Retinopathy of Prematurity / therapy*
  • Retrospective Studies
  • Risk Factors
  • Survival Rate / trends